The DOI matches its Crossref record; 165 of the 165 references it cites were found in a registry or an index.
The molecular genetics of Marfan syndrome and related microfibrillopathies
Open accessAbstract
Mutations in the gene for fibrillin-1 (FBN1) have been shown to cause Marfan syndrome, an autosomal dominant disorder of connective tissue characterised by pleiotropic manifestations involving primarily the ocular, skeletal, and cardiovascular systems. Fibrillin-1 is a major component of the 10-12 nm microfibrils, which are thought to play a role in tropoelastin deposition and elastic fibre formation in addition to possessing an anchoring function in some tissues. Fibrillin-1 mutations have also been found in patients who do not fulfil clinical criteria for the diagnosis of Marfan syndrome, but have related disorders of connective tissue, such as isolated ectopia lentis, familial aortic aneurysm, and Marfan-like skeletal abnormalities, so that Marfan syndrome may be regarded as one of a range of type 1 fibrillinopathies. There appear to be no particular hot spots since mutations are found throughout the entire fibrillin-1 gene. However, a clustering of mutations associated with the most severe form of Marfan syndrome, neonatal Marfan syndrome, has been noted in a region encompassing exons 24 to 32. The gene for fibrillin-2 (FBN2) is highly homologous to FBN1, and mutations in FBN2 have been shown to cause a phenotypically related disorder termed congenital contractural arachnodactyly. Since mutations in the fibrillin genes are likely to affect the global function of the microfibrils, the term microfibrillopathy may be the most appropriate to designate the spectrum of disease associated with dysfunction of these molecules. The understanding of the global and the molecular functions of the fibrillin containing microfibrils is still incomplete and, correspondingly, no comprehensive theory of the pathogenesis of Marfan syndrome has emerged to date. Many, but not all, fibrillin-1 gene mutations are expected to exert a dominant negative effect, whereby mutant fibrillin monomers impair the global function of the microfibrils. In this paper we review the molecular physiology and pathophysiology of Marfan syndrome and related microfibrillopathies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calcium's Role in Mechanotransduction during Muscle Development
Benavides Damm, T., & Egli, M. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000356667 · Cited by 14,502
Integrins: Versatility, modulation, and signaling in cell adhesion
Hynes, R. O. (1992) · Cell · doi:10.1016/0092-8674(92)90115-s · Cited by 9,859
Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene
Dietz, H. C., Cutting, C. R., Pyeritz, R. E., Maslen, C. L., Sakai, L. Y., Corson, G. M., Puffenberger, E. G., Hamosh, A., Nanthakumar, E. J., Curristin, S. M., et al. (1991) · Nature · doi:10.1038/352337a0 · Cited by 2,070
Revised diagnostic criteria for the Marfan syndrome
De Paepe, A., Devereux, R. B., Dietz, H. C., Hennekam, R. C. M., & Pyeritz, R. E. (1996) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19960424)62:4<417::aid-ajmg15>3.0.co;2-r · Cited by 1,572
Functional inactivation of genes by dominant negative mutations
Herskowitz, I. (1987) · Nature · doi:10.1038/329219a0 · Cited by 1,160
Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils.
Sakai, L. Y., Keene, D. R., & Engvall, E. (1986) · The Journal of cell biology · doi:10.1083/jcb.103.6.2499 · Cited by 1,157
Shores, J., Berger, K. R., Murphy, E. A., & Pyeritz, R. E. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405123301902 · Cited by 1,071
Connective Tissue and Its Heritable Disorders: Molecular, Genetic, and Medical Aspects
(2002) · Wiley eBooks · doi:10.1002/0471221929 · Cited by 949
Rebay, I., Fleming, R. J., Fehon, R. G., Cherbas, L., Cherbas, P., & Artavanis-Tsakonas, S. (1991) · Cell · doi:10.1016/0092-8674(91)90064-6 · Cited by 772
Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes
Lee, B., Godfrey, M., Vitale, E., Hori, H., Mattei, M.-G., Sarfarazi, M., Tsipouras, P., Ramirez, F., & Hollister, D. W. (1991) · Nature · doi:10.1038/352330a0 · Cited by 671
Self-citation
Cited by
Kielty, C. M., Sherratt, M. J., & Shuttleworth, C. A. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.14.2817 · Cited by 841
Tadros, T. M., Klein, M. D., & Shapira, O. M. (2009) · Circulation · doi:10.1161/circulationaha.108.795401 · Cited by 430
Vascular wall extracellular matrix proteins and vascular diseases
Xu, J., & Shi, G.-P. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.07.008 · Cited by 381
Latent TGF-β Binding Proteins: Extracellular Matrix Association and Roles in TGF-β Activation
Hyytiäinen, M., Penttinen, C., & Keski-Oja, J. (2004) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360490460933 · Cited by 354
Cellular and molecular mechanisms of thoracic aortic aneurysms
El-Hamamsy, I., & Yacoub, M. H. (2009) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.191 · Cited by 330
Metadata
- Authors
- Robinson, P. N., & Godfrey, M.
- Venue
- Journal of Medical Genetics
- Publisher
- BMJ
- Published
- 2000-01-01
- Volume
- 37
- Issue
- 1
- Pages
- 9-25
- ISSN
- 0022-2593 (ISSN-L)
- 1468-6244
- OpenAlex
- W2144628055
- Cited by
- 311
- References
- 165
- FWCI
- 9.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The molecular genetics of Marfan syndrome and related microfibrillopathies. https://app.cochat.ai/papers/10.1136/jmg.37.1.9
- The paper
- Robinson, P. N., & Godfrey, M. (2000). The molecular genetics of Marfan syndrome and related microfibrillopathies. Journal of Medical Genetics. https://doi.org/10.1136/jmg.37.1.9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.